AliperTherapeutics
Bellinzona
About AliperTherapeutics
AliperTherapeutics offers pharmacological treatments for prostate cancer using a bacteria-based medication. Its technology promises to improve the efficacy of existing medicines and delay the onset of severe types of the disease. The headquarters of the corporation are in Bellinzona, Switzerland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Non-Equity Assistance (Dec 2022)
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/alipertherapeutics-3768507 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.